“The true investor…will do better if he forgets about the stock market and pays attention to his dividend returns.” Benjamin Graham
History has a way of rewarding those who nap while the world burns. Dividends, those quiet little alms from corporate titans, have sustained investors through wars, plagues, and the occasional financial collapse. Here, then, are two industrial leviathans that will whisper cash into your pillow while you dream of simpler times.
Skybound Stability
Lockheed Martin (LMT) is the kind of company that builds machines to destroy things. Specifically, it builds F-35s-jet fighters that cost more than most small countries’ annual budgets. The U.S. Department of Defense, that endless money pit with a budget larger than entire continents, has handed Lockheed a contract that stretches into the 2060s. So it goes.
Russia, China, Iran, and North Korea-all paragons of peace, no doubt-ensure Lockheed’s ledger stays full. The Pentagon’s obsession with modernizing its toys (read: weapons) means Lockheed’s engineers will keep designing death-dealing drones and stealth jets for decades. Recently, they unveiled Vectis, a drone that will fly alongside fighter jets like a mechanical seagull. Even if robots eventually replace humans in cockpits, Lockheed’s got a 75% revenue lifeline from the DoD. A stable business, if you ignore the moral quandaries. Or don’t. Your call.
Lockheed trades at 27 times earnings, a modest price for a company that pays 2.7% annually. Its future is written in red ink and titanium. So it goes.
Brewing Empire
Ambev (ABEV), a subsidiary of Anheuser-Busch InBev, rules the beer taps of Latin America with a grip as firm as a monk’s. In Brazil, it owns 60% of the beer market; in Bolivia, over 70%. It sells Budweiser, Corona, and PepsiCo products to a region where per capita beer consumption is still low. The math is simple: more people, more thirst, more profit. Unless you count the occasional protest. But protests are fleeting. So it goes.
Ambev’s secret weapon? Premium imports. As Latin Americans trade downmarket domestic brews for American lagers, Ambev’s parent company slaps a “premium” label on its cans and charges twice as much. Regional competitors, meanwhile, struggle to match its scale. They’ll try. They’ll fail. History favors monopolies. And 7.6% dividend yields. A dangerous combination.
Ambev’s stock chart looks like a cobra uncoiling. Investors, take note: this is a company that thrives when economies grow-and even when they don’t. So it goes.
Time to Buy?
Both stocks are relics of an era when businesses could outlast empires. Lockheed’s F-35 contract is a time capsule of Cold War paranoia, now repurposed for 21st-century dread. Ambev’s beer taps flow regardless of political tremors. They are not get-rich-quick schemes. They are get-rich-slowly fortresses. Build your portfolio around them, and you might outlive the next crisis. Or not. The future is a fickle thing. But the dividends? Those are as certain as gravity. So it goes. 🚀
Read More
- The Unexpected Triumph of Novo Nordisk: A Dividend Hunter’s Delight
- Gold Rate Forecast
- Bitcoin’s Paradox: Billionaire Buys, Price Stagnates
- Big Sell on Big Data: When Even the Suits Say ‘Enough’s Enough’
- XRP On The Brink: Are We About To Witness Crypto Fireworks Or Just Another Fizzle? 🎭
- ETF Exit: A Tale of Diversification and Dwindling Dreams
- General Hospital Recap, July 23 Episode: Drew Suspects Willow of Stalking Daisy
- Elden Ring’s Switch 2 port delayed into 2026 by FromSoftware for “performance adjustments,” and people are surprisingly OK about it: “I’d rather it releases in a better state”
- AI Investing Through Dan Ives’ Lens: A Revolutionary ETF
- Superman Lore Changed Forever? YOU WON’T BELIEVE WHAT HAPPENS!
2025-09-29 03:45